Myriad Genetics, Inc. ( MYGN) - Stock Earnings
MYGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 4, 2026, midnight | — / — | — | — / — | — |
MYGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -27.4 million USD | 205.7 million USD |
| 2025Q4 | -7.9 million USD | 209.8 million USD |
| 2026Q1 | -34.1 million USD | 200.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MYGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -263.3 million USD | 753.2 million USD |
| 2024 | -127.3 million USD | 837.6 million USD |
| 2025 | -365.9 million USD | 824.5 million USD |
| 2026 Est. | — | — |
MYGN
Price: $5.66
Earnings Per Share: -4.31 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 315100
Ebitda: 17.5 millionMarket Capitalization: 565.7 million